Skip to: Content
Skip to: Site Navigation
Skip to: Search

September 8, 2008 12:49:17 PM CDT

Learn about Newser Points »

Stories related to: FDA

Stories

Stories 21 - 40 of 105

<< Prev 1 2 3 4 5 6 Next >>
  • April 2008

    • Deadly Heparin Found in 11 Nations

      New York Times  |  Apr 22, 08 7:17 AM CDT

      Deadly Heparin Found in 11 Nations

      (Newser) - The FDA has traced a contaminated blood thinner from a Chinese factory to 11 countries, the New York Times reports. Severe reactions to the contaminated heparin have been linked to the deaths of 81 Americans, but it wasn't immediately clear if the drug may have triggered fatalities in other countries. Chinese officials have denied that the contamination caused any deaths and have demanded to be allowed to inspect the US plant where the heparin was packaged. More »

    • Feds Warn of Chemical in Plastics

      Washington Post  |  Apr 15, 08 6:11 PM CDT

      Feds Warn of Chemical in Plastics

      (Newser) - A federal health panel warned today a chemical used to make a slew of everyday plastic items—including baby bottles—could be linked to several types of cancer, early puberty for girls and even hyperactivity, the Washington Post reports. The report urges more study and marks a reversal for the government, which previously rejected health risks associated with bisphenol A (BPA). More »

      Tags

      health  • FDA  • plastic  • baby bottle  • health advisories

    • Cancer Drug Sales Push Genentech Profits Up 12%

      Wall Street Journal  |  Apr 11, 08 8:28 AM CDT

      Cancer Drug Sales Push Genentech Profits Up 12%

      (Newser) - Biotech firm Genentech said sales of its blockbuster cancer drug Avastin fueled a first-quarter profit increase of 12%, reports the Wall Street Journal, but the $600 million in sales was below analysts’ projected $622 million, causing some to grumble the drug may have reached a sales plateau. Genentech stock edged up 0.3% in after-hours trading. More »

      Tags

      FDA  • breast cancer  • corporate earnings  • Genentech  • Avastin  • Roche Holding

    • Berkeley Fights Donation Policy Without Protests

      Inside Bay Area (Oakland)  |  Apr 8, 08 2:00 PM CDT

      Berkeley Fights Donation Policy Without Protests

      (Newser) - Several San Francisco-area campuses have banned blood drives to protest federal policies preventing sexually active gay men from donating blood, but at UC-Berkeley, students are making a point without resorting to boycotts. Instead of withholding blood on grounds the 25-year-old FDA rule is discriminatory, Cal is encouraging gay students to recruit eligible donors to give for them, the Oakland Tribune reports. More »

      Tags

      FDA  • gay  • UC Berkeley  • San Jose State University  • donated blood  • blood drives

    • J&J Hid Birth Control Patch Risks: Suit

      Bloomberg  |  Apr 6, 08 4:40 PM CDT

      J&amp;J Hid Birth Control Patch Risks: Suit

      (Newser) - Johnson & Johnson doctored data to get its birth control patch FDA-approved, according to a class action lawsuit that claims Ortho-Evra caused blood clots, heart attacks, and strokes. A J&J scientist allegedly doctored the data with a "correction factor" for the FDA, lowering estrogen-related risk by 60%: He "presented a truly misleading picture of the amount of estrogen delivered by the patch,'' the suit said. More »

  • March 2008

    • FDA Probes Suicide Link to Asthma Drug

      USA Today  |  Mar 28, 08 7:09 AM CDT

      FDA Probes Suicide Link to Asthma Drug

      (Newser) - The FDA has opened an investigation of anecdotal links between the popular asthma and allergy drug Singulair and suicidal thoughts. In the past year, manufacturer Merck has added warnings of several possible side effects of  the pill related to the nervous system, including anxiety, depression, tremors, and suicidal thinking. The FDA says its review of the drug, which had sales of more than $4.3 billion last year, may take up to nine months. More »

      Tags

      FDA  • suicide  • Merck  • asthma  • allergy  • Singulair

    • Determine Your Daddy—at the Drugstore

      MSNBC  |  Mar 27, 08 8:26 PM CDT

      Determine Your Daddy&mdash;at the Drugstore

      (Newser) - The sometimes vexing task of determining a child's father can now be solved by plunking down $29.99 at the local drugstore. A Utah company has expanded sales of its do-it-yourself DNA kit to Rite Aids in 30 states after sales soared in sample markets, MSNBC reports. Identigene of Salt Lake City expects to sell 52,000 of them this year. More »

      Tags

      FDA  • DNA  • parents  • father  • paternity test

    • Feds ID Extra Drug in Baxter's Recalled Heparin

      Wall Street Journal  |  Mar 19, 08 1:44 PM CDT

      Feds ID Extra Drug in Baxter's Recalled Heparin

      (Newser) - The Food and Drug Administration has identified the extra ingredient found in samples of Baxter’s blood-thinning drug heparin, the Wall Street Journal reports today. Some batches of the drug—recalled in January after reports of allergic reactions—contained over-sulfated chondroitin sulfate, but it is not certain that was the cause of the hundreds of reactions or 19 deaths linked to Baxter’s product. More »

    • 8 Worrying Drug Side Effects

      Forbes  |  Mar 7, 08 7:14 PM CST

      8 Worrying Drug Side Effects

      (Newser) - Despite rigorous testing, some drugs have side effects that only rear their ugly heads when introduced to the general population. Forbes catalogs some of the weirdest: Anti-smoking drug Chantix can cause insomnia and nightmares. Diet drug Alli can have unforeseen gastrointestinal side-effects; these can be counteracted by eating a low-fat diet , of all things. Mirapex, prescribed for Parkinson's and restless-leg-syndrome patients, can lead to compulsive-eating and gambling urges. More »

      Tags

      list  • FDA  • blood pressure  • drug safety  • side effects  • Chantix  • drug trials  • Mirapex  • Ambien

    • Blood Thinner Woes Hit Germany

      New York Times  |  Mar 7, 08 8:32 AM CST

      Blood Thinner Woes Hit Germany

      (Newser) - Heparin blood thinners may have sickened as many as 100 people in Germany, health officials report. The FDA is currently investigating the drug after it was linked to 19 deaths and hundreds of allergic reactions in the US, possibly due to contaminants from China. The agency is now recommending that all American heparin manufacturers test supplies for contaminants and counterfeit ingredients. More »

      Tags

      China  • Germany  • FDA  • Heparin  • Baxter International  • blood thinner  • contaminated drugs  • drug recall  • drug reactions

    • Senate Backs Product Safety Crackdown

      Los Angeles Times  |  Mar 7, 08 2:45 AM CST

      Senate Backs Product Safety Crackdown

      (Newser) - The Senate has passed a tough new product safety measure covering toys, household appliances and thousands of other products. It would ban lead in toys, increase civil penalties for hazardous products tenfold, enable more state regulation and create a database of dangerous items on the market. It also sets up a confrontation with the White House, which in the past has sided with manufacturers who oppose the bill, reports the Los Angeles Times . More »

    • FDA Finds Contaminant in Blood Thinner

      New York Times  |  Mar 5, 08 9:49 PM CST

      FDA Finds Contaminant in Blood Thinner

      (Newser) - The FDA has found a contaminant in samples of heparin, a blood thinner produced mainly in China linked to 19 deaths and nearly 800 allergic reactions in the US, the New York Times reports. The contaminant may be a counterfeit form of heparin added to reduce its manufacturing cost. The FDA is fine-tuning tests to better detect it. More »

  • February 2008

    • Feds OK Wyeth's New Antidepressant

      New York Times  |  Feb 29, 08 7:41 PM CST

      Feds OK Wyeth's New Antidepressant

      (Newser) - Antidepressant Effexor XR will soon lose patent protection, and maker Wyeth is hoping Pristiq, the successor drug approved today by the FDA, will soften the financial blow. Higher-ups at the company gush over Pristiq's advantages, including zero acclimation time and no liver interaction, and hope that sales will offset losses to generic versions of Effexor, the New York Times reports. More »

      Tags

      stock market  • FDA  • antidepressant  • Wyeth  • metabolism  • Effexor  • patent expiration

    • FDA Clears Avastin for Breast Cancer

      Associated Press  |  Feb 22, 08 6:06 PM CST

      FDA Clears Avastin for Breast Cancer

      (Newser) - The FDA has approved a drug currently prescribed to treat lung and colon cancer for use on breast cancer patients, the AP reports. The decision defies the advice of the FDA's own advisory panel, which recommended that Avastin not be used to treat breast cancer on the grounds that it slowed tumor growth without increasing life expectancy. Patient advocates are thrilled with the ruling. More »

      Tags

      FDA  • breast cancer  • lung cancer  • colon cancer  • tumors  • Genentech  • mortality  • Avastin

    • FDA Approved Wrong China Firm

      Washington Post  |  Feb 19, 08 6:26 AM CST

      FDA Approved Wrong China Firm

      (Newser) - The Chinese facility that supplied the active ingredient of the blood-thinner heparin, linked to hundreds of adverse reactions and four US deaths, was never inspected by the FDA because the agency confused it with another plant of the same name, the Washington Post reports. The company was given approval based on an earlier FDA inspection of the other factory. "The wrong firm was put into the database," said the FDA's deputy director. More »

    • FDA Delay Cost 22,000 Lives: Doctor

      CBS  |  Feb 15, 08 7:53 AM CST

      FDA Delay Cost 22,000 Lives: Doctor

      (Newser) - A prominent researcher who revealed widespread fatalities associated with the heart surgery drug Trasylol says 22,000 people died because of the FDA's delay in blowing the whistle on the drug after his study was published. Drugmaker Bayer also failed to disclose negative results of its own study. In a 60 Minutes interview to air Sunday, Dr. Dennis Mangano says the FDA waited more than a year to pull Trasylol—until after it was banned in Germany. More »

    • Chinese Factory Linked to Deadly US Drug

      Wall Street Journal  |  Feb 14, 08 4:46 AM CST

      Chinese Factory Linked to Deadly US Drug

      (Newser) - The active ingredient in a drug linked to four deaths and hundreds of adverse reactions in the US has been traced to a Chinese factory which has never been inspected by the FDA, reports the Wall Street Journal . The drug is a blood-thinner made by Baxter International, a   version of the generic drug heparin, which is used in heart surgery and dialysis to prevent blood from clotting. Baxter has halted production of the drug. More »

      Tags

      China  • FDA  • Heparin  • Baxter International  • deaths

    • Deaths Spark FDA Review of Botox Safety

      Reuters  |  Feb 8, 08 5:05 PM CST

      Deaths Spark FDA Review of Botox Safety

      (Newser) - The FDA is investigating the safety of Botox and a competing medication after learning that the drug might have caused death and breathing problems in children being treated for cerebral palsy, Reuters reports. That's not an approved use for the cosmetic drug; docs administer it because it can block nerve impulses and relax spasmodic muscles. No adult deaths were reported, according to the Wall Street Journal . More »

      Tags

      FDA  • drug companies  • drug test  • Botox  • side effects

    • US, Chinese Firms Charged in Pet Food Scandal

      Associated Press  |  Feb 6, 08 6:16 PM CST

      US, Chinese Firms Charged in Pet Food Scandal

      (Newser) - US authorities today charged an American company and two Chinese businesses with manufacturing and importing tainted ingredients in pet food that killed thousands of cats and dogs last year, the AP reports. Las Vegas-based ChemNutra and its owners face a felony conspiracy charge and 26 misdemeanor counts for selling adulterated and misbranded food. The Chinese businesses face 26 counts each. More »

      Tags

      China  • FDA  • pets  • federal indictment  • pet food recalls

    • Puerto Rican Drug Plants Shipped Tainted Pills: FDA

      Associated Press  |  Feb 6, 08 1:38 PM CST

      Puerto Rican Drug Plants Shipped Tainted Pills: FDA

      (Newser) - The Caribbean island that produces 13 of the 20 best-selling drugs in the US has sold tainted pills and is struggling with quality control at its pharmaceutical plants, AP reports.  FDA inspections of 13 Puerto Rican plants between 2003 and 2007 revealed problems such as machinery pins left in drug bottles and foreign material embedded in tablets. More »

      Tags

      FDA  • Puerto Rico  • GlaxoSmithKline  • pharmaceutical  • Wyeth

Stories 21 - 40 of 105

<< Prev 1 2 3 4 5 6 Next >>

Today's Most Popular

Premium Articles from HighBeam

Find more articles like this

What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »